The Evidence Based Rheumatology Podcast

The Evidence Based Rheumatology Podcast header image 1

E86: Target Trials and Causality in Rheumatology

June 6th, 2022

Mixing it up again this week to discuss an editorial by Miguel Hernan and a systematic review of target trials in rheumatology. It's kind of a fun free-form stream of consciousness. Hope you enjoy! Links: 

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888052/

https://pubmed.ncbi.nlm.nih.gov/32381560/

 

E85: Challenging Wisely

May 23rd, 2022

Quick episode today. I wanted to share an editorial that was recently published in Rheumatology, where I and co-authors (Shannon Tai and Natalie Anumolu) discuss lessons from recent trials in AAV and SLE. 

 

Link to editorial: https://pubmed.ncbi.nlm.nih.gov/35438142/ 

E84: The JAKapocalypse (AKA ORAL Surveillance)

May 9th, 2022

After some delay, I finally get around to discussing ORAL-Surveillance, a post-marketing safety study of tofacitinib for rheumatoid arthritis. It's an incredibly important trial that will likely affect how all of us practice for the foreseeable future. Link to paper: 

 

https://www.nejm.org/doi/full/10.1056/NEJMoa2109927

E83: Effectiveness of COVID-19 Vaccines

April 25th, 2022

After a winter hiatus, the podcast is back! Today I wanted to dive into a 'hotbutton' issue - the question of whether (or not) COVID-19 vaccines "work" for patients with rheumatic diseases. My answer is an emphatic "yes," albeit with a few caveats. Here are the papers I discuss: 

 

https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(22)00034-0/fulltext

https://pubmed.ncbi.nlm.nih.gov/35441151/

E82: LoVAS Trial for ANCA Vasculitis

November 4th, 2021

Hello again! Snappy episode this week about the exciting LoVAS trial, which compared a reduced dose steroid taper for ANCA vasculitis. Be sure to drop by my website at ebrheum.com to subscribe to my newsletter! 

E81: Vasculitis Guidelines E7: Takayasu Arteritis with Dr. Andy Abril

July 12th, 2021

In this episode, I talk with Dr. Andy Abril, Chair at the Division of Rheumatology at the Mayo Clinic in Jacksonville Florida.  Dr. Abril is one of the lead authors for the 2021 ACR Guidelines on  Takayasu’s arteritis.

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

E80: Vasculitis Guidelines E6 - Polyarteritis Nodosa with Dr. Jason Springer

July 11th, 2021

In this episode, I talk with Dr. Jason Springer, Co-Director of the Vanderbilt Vasculitis Center, about the guidelines for PAN  He is one of the lead authors for the ACR/VF Guidelines for Polyarteritis Nodosa.

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

E79: Vasculitis Guidelines E5 - GCA with Dr. Mehrdad Maz

July 10th, 2021

On today's episode I discuss GCA with Dr. Mehrdad Maz.  He is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section and served on the Steering Core Committee of the ACR-VF Vasculitis Treatment Guidelines. We cover a lot of great topics!

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

E78: Vasculitis Guidelines #4 - EGPA with Dr. Phil Seo

July 9th, 2021

In today's episode, I talk with Dr. Mehrdad Maz about the newly published guidelines for giant cell arteritis (GCA).  Dr. Maz is the Division Director of the Kansas University Allergy, Clinical Immunology and Rheumatology Section. He serves on the Steering Core Committee of the ACR-VF Vasculitis Treatment Guidelines. 

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

E77: Vasculitis Guidelines #3 - ANCA Vasculitis with Dr. Sharon Chung

July 8th, 2021

The guidelines have finally arrived!  I'm kicking off the series today with a conversation about the ANCA vasculitis guidelines.  My guest is Dr. Sharon Chung, the director of the UCSF Vasculitis Clinic and the lead investigator on the ACR/Guideline committee. She provided a LOT of great insights; have a listen and let us know what you think! 

This project was done in partnership with the Vasculitis Foundation. To review the complete guidelines, visit
https://dev.vasculitisfoundation.org/2021-acr-vf-vasculitis-guidelines/ or vasculitisfoundation.org. You can find them on Twitter @vasculitisfound and I am @ebrheum. Thanks for listening! 

Podbean App

Play this podcast on Podbean App